USPTO serial 79266586
INVENTAGE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 9, 2020
- Examiner
- KLEINMAN, CORINNE ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with INVENTAGE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Seongnam-si, G, KR
Seongnam-si, G, KR
Seongnam-si, G, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Paul G. Johnson
Paul G. Johnson Maschoff Brennan1389 Center Drive, Suite 300Park City, UT 84098UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicinal infusions for treating dementia, diabetes, obesity, andropathy, alopecia, incurable disease, chronic disease, lipolysis, and boosting the immune system; Medicinal infusions for treating dirofilaria immitis diseases, infectious diseases, skeletal and muscular disorders, cardiovascular and circulatory diseases, nervous system diseases, ocular disorders, respiratory diseases, gastrointestinal diseases, endocrine diseases, kidney diseases, hormonal diseases, and oncological diseases and disorders of animals; implantable medicines in the nature of surgical implants comprised of living tissues; pharmaceutical compositions for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical compositions for animal skincare; pharmaceutical compositions for skin care; pharmaceutical compositions for treating dirofilaria immitis diseases, infectious diseases, skeletal and muscular disorders, cardiovascular and circulatory diseases, nervous system diseases, ocular disorders, respiratory diseases, gastrointestinal diseases, endocrine diseases, kidney diseases, hormonal diseases, and oncological diseases and disorders of animals; medicines for human purposes, namely, medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; drugs in the nature of pharmaceutical preparations for medical purposes, namely, for the treatment of oncological, gastrointestinal, metabolic, chronic, endocrine, respiratory, neurological and ophthalmic diseases and disorders; therapeutic drugs and agents in the nature of therapeutic pharmaceutical and agents for the treatment of oncological, gastrointestinal, metabolic, chronic, endocrine, respiratory, neurological and ophthalmic diseases and disorders; therapeutic drugs and agents in the nature of therapeutic pharmaceutical and agents for treating dirofilaria immitis diseases, infectious diseases, skeletal and muscular disorders, cardiovascular and circulatory diseases, nervous system diseases, ocular disorders, respiratory diseases, gastrointestinal diseases, endocrine diseases, kidney diseases, hormonal diseases, and oncological diseases and disorders of animals; chemical preparations for pharmaceutical purposes, namely, for the treatment of oncological, gastrointestinal, metabolic, chronic, endocrine, respiratory, neurological and ophthalmic diseases and disorders | ACTIVE | — |
| 010 | Medical apparatus and instruments for use in endovascular, cardiovascular, and endoscopy procedures; medical instruments for use in drug delivery systems; medical instruments for use in monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events; medical instruments for use in treating osteoarthritis, osteoporosis, osteotraumatic injuries, degenerative bone diseases and joint diseases; medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters; medical instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical filler apparatus in the nature of synthetic filler and extender material to serve as replacement for bone; medical apparatus and instruments, namely, infusion and injection devices for administering pharmaceuticals; diagnostic apparatus and instruments for medical purposes, namely, medical diagnostic apparatus for testing blood sugar levels, cancer cells, DNA, urinary protein, and cholesterol level; injection device for pharmaceuticals; medical apparatus, namely, infusion and injection devices for administering pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Inventage Lab Inc.
- Other trademarks owned by Inventage Lab Inc.
- Other trademarks owned by Inventage Lab Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named INVENTAGE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 9, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 28, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 25, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 2, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 2, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 9, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 9, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 24, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 24, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 4, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 24, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 23, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 23, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 19, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 1, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 1, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 25, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 24, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 17, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 12, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 5, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |